The Veterinary Anti-infectives Market size was valued at USD 8265 million in 2024 and is anticipated to reach USD 13074 million by 2032, at a CAGR of 5.9% during the forecast period (2024-2032).
REPORT ATTRIBUTE
DETAILS
Historical Period
2020-2024
Base Year
2024
Forecast Period
2025-2032
Veterinary Ant-infectives Market Size 2024
USD 8265 Million
Veterinary Ant-infectives Market, CAGR
5.9%
Veterinary Ant-infectives Market Size 2032
USD 13074 Million
Key drivers of market growth include the increasing prevalence of zoonotic diseases, the demand for high-quality animal-based products, and advancements in veterinary medicine. Additionally, the rise in the adoption of companion animals, such as dogs and cats, and the growth of the livestock sector, particularly in developing economies, further propel the market. The rising focus on preventing infections in animals, rather than treating them, has led to the adoption of anti-infectives as a preventive measure in veterinary care. Moreover, the growing trend of pet humanization and heightened awareness of animal welfare significantly contribute to the market’s expansion.
Regionally, North America holds a significant share of the market, driven by the well-established veterinary healthcare infrastructure and the rising demand for companion animals. The Asia Pacific region is expected to witness the highest growth rate due to the increasing consumption of animal-based products, growing awareness of animal health, and improving healthcare infrastructure in emerging economies like China and India. The strengthening of veterinary regulations in these regions also supports the demand for effective anti-infectives.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
The Veterinary Anti-infectives Market is valued at USD 8,265 million in 2024 and is projected to reach USD 13,074 million by 2032, with a CAGR of 5.9% during the forecast period.
The rising prevalence of zoonotic diseases is driving demand for effective veterinary anti-infectives to control infections in animals and prevent their spread to humans.
The demand for high-quality animal-based products, including meat and dairy, is fueling market growth, as veterinary anti-infectives ensure the health and safety of animals involved in food production.
The increasing adoption of companion animals, particularly in urban areas, is contributing to the growing need for anti-infectives, as pet owners prioritize their pets’ health and well-being.
Advancements in veterinary medicine, including more effective treatments and innovations in drug formulations, are enhancing the accessibility and efficiency of anti-infectives in veterinary care.
Antimicrobial resistance (AMR) poses a significant challenge, as overuse and misuse of anti-infectives in animals lead to resistant strains, demanding more stringent regulations and new treatment innovations.
Regionally, North America holds a 35% market share, driven by its strong veterinary infrastructure and increasing demand for companion animal care, while the Asia Pacific region, with a 30% market share, is poised for rapid growth due to rising animal health awareness and livestock sector expansion.
Market Drivers:
Rising Prevalence of Zoonotic Diseases
The increasing prevalence of zoonotic diseases is a significant driver of the Veterinary Anti-infectives Market. Zoonotic diseases, which can be transmitted between animals and humans, have heightened the focus on preventing and managing infections in animals. With the growing concern over public health and safety, there is a rising demand for effective veterinary anti-infectives to control the spread of these diseases. Governments and healthcare organizations are increasingly prioritizing the treatment and prevention of zoonotic diseases, driving the market’s growth.
For instance, following vaccination with MSD Animal Health’s Nobilis Salenvac ETC, studies demonstrated a significant reduction in organ colonization for Salmonella Enteritidis after a challenge was administered at 48 weeks post-vaccination.
Demand for High-Quality Animal-Based Products
The demand for high-quality animal-based products is another key driver of the Veterinary Anti-infectives Market. As global populations grow, the need for safe and nutritious meat, dairy, and other animal-based products rises. Consumers are becoming more conscious of the quality and safety of these products, which has led to greater emphasis on animal health. Veterinary anti-infectives play a crucial role in ensuring that animals remain healthy and free from infections, which is essential to maintaining the quality of the products derived from them.
For instance, researchers at Purdue University developed an on-site test for bovine respiratory disease that provides a result in under 60 minutes.
Adoption of Companion Animals
The growing adoption of companion animals, especially in urban and developed areas, is significantly influencing the Veterinary Anti-infectives Market. Pet owners are increasingly focused on ensuring the health and well-being of their pets, which leads to increased demand for veterinary care, including the use of anti-infectives. This trend, coupled with the rising awareness of zoonotic diseases, drives the market for veterinary anti-infectives, as owners look to protect their pets from infections.
Advancements in Veterinary Medicine
Advancements in veterinary medicine have led to more effective treatments for animal infections, directly influencing the Veterinary Anti-infectives Market. New technologies and innovations in drug formulations allow for more precise and effective treatments, improving animal health outcomes. Veterinary professionals are now equipped with better tools to combat infections, ensuring that animals receive timely and effective care. These advancements continue to support market growth by enhancing the overall effectiveness and accessibility of veterinary anti-infectives.
Market Trends:
Shift Towards Preventive Healthcare in Veterinary Medicine
A prominent trend in the Veterinary Anti-infectives Market is the shift towards preventive healthcare rather than reactive treatments. Pet owners and livestock farmers are increasingly prioritizing preventive measures, including vaccination and the use of anti-infectives, to reduce the risk of infections in animals. This trend is driven by the growing awareness of animal welfare and the economic benefits of preventing disease outbreaks. By investing in preventive healthcare, animal health professionals can avoid costly treatment regimens and enhance productivity in livestock farming. Preventive care has become a cornerstone of modern veterinary practices, and the demand for effective anti-infectives continues to rise as a key part of this strategy.
For instance, in a challenge study of the Porcilis® APP vaccine, the number of pigs with lung lesions was reduced to 4 in the vaccinated group, while all 10 pigs in the unvaccinated control group developed lesions.
Rising Adoption of Targeted and Specific Anti-infectives
The Veterinary Anti-infectives Market is witnessing an increasing preference for targeted and species-specific anti-infective treatments. Advances in veterinary medicine have led to the development of more precise formulations that cater to specific pathogens and animal species. These targeted treatments offer higher efficacy rates while minimizing adverse effects. Animal healthcare professionals are adopting these tailored solutions to improve treatment outcomes and reduce the risk of resistance development. This trend aligns with the growing focus on antimicrobial stewardship, encouraging the responsible use of anti-infectives to preserve their effectiveness in the long term. The market is adapting to these advancements, with increased demand for products that are both effective and tailored to individual animal health needs.
For instance, real-world data on Elanco’s Canine Parvovirus Monoclonal Antibody showed that puppies receiving the targeted treatment spent an average of 1.87 fewer days in the hospital.
Market Challenges Analysis:
Antimicrobial Resistance in Veterinary Care
One of the primary challenges in the Veterinary Anti-infectives Market is the rising issue of antimicrobial resistance (AMR). The overuse and misuse of anti-infectives in both companion animals and livestock have contributed to the development of resistant strains of bacteria, rendering some treatments ineffective. This poses a significant threat to animal health and complicates efforts to control infections. The increasing prevalence of AMR demands stricter regulations, better antimicrobial stewardship practices, and the development of novel treatments. However, combating AMR requires substantial investment in research and the implementation of stringent guidelines, which can pose challenges for veterinary professionals and stakeholders.
Regulatory Hurdles and Compliance
The Veterinary Anti-infectives Market faces ongoing challenges related to regulatory hurdles and compliance. Governments across the globe have implemented more stringent regulations for the approval and use of veterinary anti-infectives, especially in the face of growing concerns about food safety and public health. These regulations aim to minimize the risk of drug residues in animal-derived products and curb the misuse of antibiotics. While these regulations are necessary, they can delay the availability of essential anti-infective products in the market, leading to supply chain disruptions. The cost of complying with these standards also burdens manufacturers, impacting the market’s growth potential.
Market Opportunities:
Growing Demand for Companion Animal Health Products
The increasing adoption of companion animals presents a significant opportunity for the Veterinary Anti-infectives Market. As pet ownership continues to rise globally, pet owners are becoming more concerned with their pets’ health and well-being. This shift towards preventive care, along with the rising awareness of zoonotic diseases, has led to a growing demand for anti-infectives tailored to companion animals. The market is poised to benefit from this trend, with increased demand for vaccines, antibiotics, and other anti-infective treatments designed specifically for pets. The expansion of veterinary clinics and the rise of online pet pharmacies further contribute to the growing market potential.
Advancements in Antimicrobial Stewardship Initiatives
There is a growing opportunity within the Veterinary Anti-infectives Market through the promotion of antimicrobial stewardship initiatives. Governments, regulatory bodies, and industry stakeholders are increasingly focused on reducing the overuse of anti-infectives and promoting their responsible use in veterinary care. These initiatives create a demand for more efficient and targeted treatments, encouraging the development of new anti-infective products with minimal resistance risks. The market can capitalize on these opportunities by offering innovative solutions that align with global efforts to combat antimicrobial resistance, ensuring long-term sustainability for both human and animal health.
Market Segmentation Analysis:
By Product
The Veterinary Anti-infectives Market is primarily segmented into antibiotics, vaccines, antifungals, and antivirals. Antibiotics dominate the market due to their widespread use in preventing and treating bacterial infections in both companion animals and livestock. Vaccines are also crucial for preventing infectious diseases, especially in livestock and poultry, supporting the growth of the segment. Antifungals and antivirals, though smaller, are gaining traction due to their role in addressing fungal and viral infections, respectively, which can severely impact animal health and productivity.
For instance, Merck Animal Health is investing $895 million to expand its manufacturing facility in De Soto, Kansas, which will increase its capacity for producing large-molecule vaccines and other biologic products.
By Animal Type
The Veterinary Anti-infectives Market is segmented into companion animals, livestock, and others. Companion animals, particularly pets such as dogs and cats, account for a significant share of the market as owners increasingly seek to protect their pets from infections. Livestock, including cattle, poultry, and swine, also represent a large portion of the market due to the need to ensure the health of animals involved in food production. The growing awareness of animal welfare and zoonotic diseases is contributing to the expanding demand for anti-infectives in this segment.
For instance, a study utilizing the Ceva Lung Program demonstrated a significant reduction in lung lesions in vaccinated pigs, with the APP-index (a measure of pleurisy) dropping from 1.2 to 0.1 after vaccination.
By Route of Administration
The route of administration segment includes oral, parenteral, and topical administration. Oral administration holds the largest share due to ease of use and convenience for treating a wide range of infections in both companion animals and livestock. Parenteral administration, particularly injectable solutions, is commonly used for more severe infections that require rapid absorption and higher efficacy. Topical administration is gaining popularity for treating external infections in companion animals.
Segmentations:
By Product:
Antibiotics
Vaccines
Antifungals
Antivirals
By Animal Type:
Companion Animals
Livestock
Others
By Route of Administration:
Oral
Parenteral
Topical
By Type:
Prescription-Based Anti-infectives
Over-the-Counter (OTC) Anti-infectives
By Distribution Channel:
Veterinary Clinics
Online Pharmacies
Retail Pharmacies
Veterinary Hospitals
By Region:
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
South-east Asia
Rest of Asia Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of the Middle East and Africa
Regional Analysis:
North America: Dominance in Veterinary Healthcare Infrastructure
North America holds a 35% share of the Veterinary Anti-infectives Market, driven by its advanced veterinary healthcare infrastructure and high demand for companion animal care. The region’s well-established regulatory frameworks ensure stringent standards for animal health products, enhancing the quality and safety of veterinary anti-infectives. The rising pet adoption rates, combined with increasing concerns about zoonotic diseases, contribute to the market’s growth. The U.S. and Canada lead in the development and adoption of new anti-infective treatments, supported by robust research and development activities. As the demand for animal-based products continues to grow, the need for effective veterinary care, including anti-infectives, will expand.
Asia Pacific: Fastest-Growing Market with Rising Animal Health Awareness
The Asia Pacific region is expected to account for 30% of the Veterinary Anti-infectives Market, with the highest growth rate projected in the coming years. Rapid urbanization, growing livestock populations, and increasing animal health awareness are driving this growth. Countries like China and India are experiencing significant growth in the livestock sector, with a focus on improving animal health standards and food safety. The rising consumption of animal-based products and a shift toward preventive care are major drivers of market expansion. Veterinary anti-infectives play a crucial role in maintaining the health of livestock, especially in large-scale farming operations, making this region a key growth opportunity for the market.
Europe: Strong Focus on Regulatory Compliance and Animal Welfare
Europe holds a 25% share of the Veterinary Anti-infectives Market, with a strong regulatory framework and increasing focus on animal welfare. The European Union has stringent regulations regarding the use of veterinary medicines, promoting the responsible use of anti-infectives to curb antimicrobial resistance. This regulatory environment supports the development and deployment of high-quality, safe products. The increasing demand for both companion animal care and livestock health solutions, combined with the region’s focus on sustainable and responsible farming practices, will drive steady growth in the Veterinary Anti-infectives Market. Leading European countries such as Germany, France, and the UK continue to invest in research and development to advance the market.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
The Veterinary Anti-infectives Market is highly competitive, with numerous global and regional players striving to gain market share. Leading companies such as Zoetis Inc., Merck & Co., Elanco Animal Health, and Bayer AG dominate the market through their wide range of anti-infective products and strong distribution networks. These players invest heavily in research and development to introduce innovative solutions, such as targeted vaccines and advanced antibiotics, to address emerging animal health challenges. Smaller, regional companies also contribute by offering specialized products for specific animal types or geographical needs. Competitive strategies include product diversification, strategic alliances, and expanding into emerging markets where animal health awareness is growing. Price competition, along with regulatory compliance, plays a critical role in shaping market dynamics. The increasing focus on antimicrobial resistance further influences the development of safer, more effective veterinary anti-infective solutions.
Recent Developments:
In June 2025, Zoetis launched AI Masses, a new artificial intelligence feature for its Vetscan Imagyst diagnostic platform to screen common masses in-clinic.
In July 2025, Merck announced a definitive agreement to acquire Verona Pharma, gaining the COPD treatment Ohtuvayre®, with the transaction expected to close in the fourth quarter of 2025.
In May 2025, Dechra announced the FDA approval of Otiserene, a single-dose, long-acting treatment for canine otitis externa.
Market Concentration & Characteristics:
The Veterinary Anti-infectives Market is moderately concentrated, with a few major players holding significant market share. Leading companies, including Zoetis Inc., Merck & Co., and Elanco Animal Health, dominate through their extensive product portfolios, global reach, and strong brand recognition. These companies focus on expanding their market presence by introducing innovative anti-infective solutions and complying with stringent regulatory requirements. Smaller players are emerging in niche markets, offering specialized products for specific animal types or regions. The market is characterized by ongoing research and development to address the rising concerns of antimicrobial resistance, ensuring the development of safer and more effective anti-infectives. Competitive strategies include partnerships, acquisitions, and expanding into emerging markets where animal healthcare awareness is growing rapidly. Market entry barriers are moderate due to high regulatory standards and substantial investment required for R&D and distribution channels.
Report Coverage:
The research report offers an in-depth analysis based on Product, Animal Type, Route of Administration, Type, Distribution Channel and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook:
The Veterinary Anti-infectives Market will continue to expand as the demand for animal health products rises globally, driven by increased pet adoption and livestock farming.
The shift towards preventive healthcare in veterinary practices will further fuel the demand for anti-infectives, particularly vaccines and antibiotics.
Emerging economies, especially in Asia Pacific and Latin America, will witness a surge in market growth due to improved veterinary care and rising awareness of animal health.
Innovations in veterinary medicine, including more targeted and species-specific anti-infectives, will play a key role in shaping market dynamics.
Increasing concerns over antimicrobial resistance will prompt further regulatory changes, encouraging the development of more sustainable anti-infective solutions.
The rise of online pharmacies and e-commerce platforms will provide new channels for distribution, enhancing accessibility to veterinary anti-infectives.
Growing animal welfare awareness will push for the development of safer and more effective treatments, driving market innovation.
Veterinary professionals will increasingly adopt data-driven tools and precision medicine to deliver tailored anti-infective treatments.
Regulatory frameworks will become stricter, creating opportunities for companies that can comply with evolving standards and offer compliant products.
Strategic mergers and acquisitions will continue, as large companies look to expand their product portfolios and enter new geographical regions.
For Table OF Content – Request For Sample Report –
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
Request Sample
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Frequently Asked Questions
What is the current market size for Veterinary Anti-infectives, and what is its projected size in 2032?
The Veterinary Anti-infectives Market was valued at USD 8,265 million in 2024 and is anticipated to reach USD 13,074 million by 2032.
At what Compound Annual Growth Rate is the Veterinary Anti-infectives market projected to grow between 2024 and 2032?
The market is projected to grow at a CAGR of 5.9% during the forecast period from 2024 to 2032.
Which Veterinary Anti-infectives market segment held the largest share in 2024?
In 2024, the largest segment in the Veterinary Anti-infectives Market was antibiotics, due to their widespread use in both companion animals and livestock.
What are the primary factors fueling the growth of the Veterinary Anti-infectives market?
The primary factors include the increasing prevalence of zoonotic diseases, rising demand for high-quality animal-based products, advancements in veterinary medicine, and the growing adoption of companion animals.
Who are the leading companies in the Veterinary Anti-infectives market?
Leading companies in the Veterinary Anti-infectives Market include Zoetis Inc., Merck & Co., Elanco Animal Health, and Bayer AG.
Which region commanded the largest share of the Veterinary Anti-infectives market in 2024?
North America commanded the largest share of the Veterinary Anti-infectives Market in 2024, driven by its established veterinary healthcare infrastructure and high demand for companion animals.
About Author
Shweta Bisht
Healthcare & Biotech Analyst
Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing.
$4699
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis and multi-location access, making it an excellent choice for organizations with distributed workforce.
$5699
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc.’s research team. It is highly recommended for organizations seeking to execute short, customized research projects related to the scope of the purchased report.
I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.
